Synthesis of nanoniosomes loaded Artemisia deserti extract: identification of chemical compounds, antimicrobial effects and cytotoxicity of nanoniosomes

Document Type : Research Paper

Author

Department of Biology, Parand Branch, Islamic Azad University, Parand, Iran

Abstract

Introduction
Nanoniosomes are multi-layered vesicles that are used as one of the new targeted drug delivery systems today. In this study, the extract of the Artemisia deserti L. was encapsulated in nanonisomes and its antimicrobial and cytotoxic effects were studied.
Materials and Methods
In this experimental study, nanonisomes containing the extract of Artemisia deserti were synthesized and their appearance and structural characteristics were investigated. After confirming the structure, its antimicrobial and anti-biofilm effects on Klebsiella pneumoniae pathogenic strains were investigated. Finally, in order to check the biocompatibility, the colorimetric method of nanonisomes cytotoxicity was used on HFF normal fibroblast cell line.
Results
The results of niosomes synthesis showed that the synthesized nanoniosomes have a spherical structure and have a size of 125.4 ± 29.3 nm. In addition, FTIR results confirmed the synthesis of niosomes. The results of the antimicrobial effects showed that the nanoniosomes containing the medicinal extract have more significant antimicrobial and anti-biofilm effects than the extract alone, so that the minimum inhibitory concentration (MIC) of the niosomes was reduced between 2 and 4 times. Also, the cytotoxicity results showed that the synthesized niosomes do not have significant cytotoxicity effects.
Conclusion
In general, the results of this study showed that nanonisomes can act as a suitable drug delivery system for medicinal plant extract to increase the amount of antimicrobial and anti-biofilm effects. Therefore, with further studies, this system can be used as an optimal drug delivery system for medicinal purposes.

Keywords

Main Subjects

References

  1. García-Díaz M, Patiño B, Vázquez C, Gil-Serna J. A novel niosome-encapsulated essential oil formulation to prevent Aspergillus flavus growth and aflatoxin contamination of maize grains during storage. Toxins. 2019. 11(11): 646-652.
  2. Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, Alcudia A. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials. 2020. 10(7): 1403.
  3. Rawat M, Singh D, Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Bio Pharm Bulletin. 2006. 29(9): p. 1790-1798.
  4. Khaleghian M, Sahrayi H, Hafezi Y, Mirshafeeyan M, Moghaddam ZS. In silico design and mechanistic study of niosome-encapsulated curcumin against multidrug-resistant Staphylococcus aureus biofilms. Front Microbiol. 14, 1277533.
  5. Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M.

Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci. 2014. 205:187-206.

  1. Yaghoobian, M. The impact of surfactant composition and surface charge of niosomes on the oral absorption of repaglinide as a BCS II model drug. Int J Nanomedicine. 2020; 15: 8767–8781.
  2. Liu D, Yang F, Xiong F, Gu N. The smart drug delivery system and its clinical potential. Theranostics, 2016. 6(9): 1306-1323.
  3. Abdelbary, A.A, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485(1-2):235-43.
  4. Bassetti M, Carnelutti A, Graziano E, Russo A. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther. 2018. 16(10): 749-761.
  5. Fair, R.J. Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014:6:25-64.
  6. Doorduijn DJ, Rooijakkers SH, van Schaik W, Bardoel BW. Complement resistance mechanisms of Klebsiella pneumoniae. Immunobiology, 2016. 221(10): 1102-1109.
  7. Lam, M, Wick RR, Watts SC. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun, 2021. 12(1): 1-16.
  8. Podschun, R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical microbiology reviews, 1998. 11(4): 589-603.
  9. Bengoechea JA, Pessoa JS. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS microbiology reviews, 2019. 43(2): 123-144.
  10. Wang G, Zhao G, Chao X, Xie L, Wang H. The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. Inter J Environmental Res Public Health, 2020. 17(17): 6278.
  11. Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae – clinical and molecular perspectives. J Inter Med, 2020. 287(3): 283-300.
  12. Krakowska-Sieprawska A. The influence of plant material enzymatic hydrolysis and extraction conditions on the polyphenolic profiles and antioxidant activity of extracts: A green and efficient approach. Molecules, 2020. 25(9): 2074.
  13. Mirbehbahani FS, Hejazi F. Artemisia annua L. as a promising medicinal plant for powerful wound healing applications. Prog Biomater, 2020. 9(3): 139-151.
  14. Huang J, Xu H, Huang Y. Antibacterial activity of Artemisia asiatica essential oil against some common respiratory infection causing bacterial strains and its mechanism of action in Haemophilus influenzae. Microb Pathog, 2018. 14: 470-475.
  15. Findura, P. Extracts from Artemisia vulgaris L. in potato cultivation—Preliminary research on biostimulating effect. Agriculture, 2020. 10(8): 356.
  16. Choi, EJ, Kim GH. Antioxidant and anticancer activity of Artemisia princeps var. orientalis extract in HepG2 and Hep3B hepatocellular carcinoma cells. Chinese J Cancer Res. 2013. 25(5): 536.
  17. Rustaiyan A, Masoudi SH,A. Monfared ,M. Yari ,M. Kardar and A. Shahgholi, Composition of the volatile oil of Artemisia deserti krasch and Artemisia oliveriana J. Gayex DC. from Iran. J Sci, I R Iran. 2000. 11(3): 213-215.
  18. Oyku Cetin E, Salmanoglu DS. Preparation of Ethanol extract of propolis loaded niosome formulation and evaluation of effects on different cancer cell lines. Nutr Cancer. 2022;74(1):265-277.

Azwanida, N., A review on the extraction methods use in medicinal plants, principle, strength and limitation. Med Aromat Plants, 2015. 4(196): 2167-0412.

  1. Elgoud Said AA, Khalaf Mahmoud B, Helmy AM. Niosomes as promising approach for enhancing the cytotoxicity of Hemimycale sp. total crude extract supported with in-silico studies. Scientific Reports. 2024. 14: 2546.
  2. Barani, M, Mirzaei M. Lawsone-loaded niosome and its antitumor activity in MCF-7 breast cancer cell line: a nano-herbal treatment for cancer. Daru, 2018. 26(1): 11-17.
  3. Ansari M. Eslami H. Preparation and study of the inhibitory effect of nano-niosomes containing essential oil from Artemisia absinthium on amyloid fibril formation. Nanomed J. 2020. 243-250.
  4. Moghtaderi M, Mirzaie A, Zabet N, Moammeri A, Mansoori-Kermani A, Akbarzadeh I, Eshrati Yeganeh F, Chitgarzadeh A, Bagheri Kashtali A, Ren Q. Enhanced antibacterial activity of Echinacea angustifolia extract against multidrug-resistant Klebsiella pneumoniae through niosome encapsulation. Nanomaterials (Basel). 2021;11(6):1573.
  5. Aparajay, P. Dev A. Functionalized niosomes as a smart delivery device in cancer and fungal infection. Eur J Pharm Sci. 2022. 168: 106052.
  6. Afereydoon, S. Multifunctional PEGylated niosomal nanoparticle-loaded herbal drugs as a novel nano-radiosensitizer and stimuli-sensitive nanocarrier for synergistic cancer therapy. Front Bioeng Biotechnol, 2022. 10: 917368.
  7. Akbarzadeh, I. Preparation, optimization and in-vitro evaluation of curcumin-loaded niosome@calcium alginate nanocarrier as a new approach for breast cancer treatment. Biology (Basel). 2021;10(3):173.
  8. Kashef, M.T, Saleh NM, Assar NH, Ramadan MA. The antimicrobial activity of ciprofloxacin-loaded niosomes against ciprofloxacin-resistant and biofilm-forming Staphylococcus aureus. Infect Drug Resist. 2020. 13: 1619-1629.
  9. Mansouri M, Khayam N, Jamshidifar E, Pourseif T, Kianian S, Mirzaie A, Akbarzadeh I, Ren Q. Streptomycin sulfate-loaded niosomes enables increased antimicrobial and anti-biofilm activities. Front Bioeng Biotechnol. 2021. 9: 745099.
  10. Barani, M. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells: Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay. Sci Rep, 2019. 9(1): 7139.
  11. Agarwal S. Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy. RSC Adv. 2018. 8(57): 32621-32636.
  12. Varshosaz J. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv, 2003. 10(4): 251-262.
  13. Qu M, Lin Q. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. J Control Release, 2018. 287:156-166.
  14. Kishore, R.S. Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis. J Pharm Sci, 2011. 100(2): 721-731.
  15. Khan, D.H. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes. J Drug Deliv Sci Technol, 2019. 50: 27-33.
Medical Journal of Mashhad university of Medical Sciences
Volume 67, Issue 3
May and June 2024
Pages 803-822

Files

Share

How to cite

Statistics